2004Chinese Journal of MisdiagnosticsRequires access

The Detection of WT1 Gene Expression in Peripheral Blood of Acute Lymphocytic Leukemia Patients Using Real Time RT-PCR Method

Zhihua Guo

Open publisher page 0 citations

Abstract

Objective:To establish a real time reverse transcription polymerase chain reaction method for detecting WT1 and to comprehend the expression levels of WT1 in chronic myeloid leukemia (CML) through examining peripheral blood of leuk emia patients.Method:39 CML patients, 26 non-leukemia patients and 16 normal human were included in this study. The method of real time RT-PCR detecting the expression of WT1 was established. The expresion levels of WT1 gene were tested using this method.Results:The expression levels of WT1 in 5 blastic crisis of CML patients were (312 000±126 965)copies/μg RNA, those of 19 within accelerat ed phase were (18 652±22 879)copies/μg, and those of 15 within chronic phase were (154±182)copies/μgRNA.Conclusion:Expression of WT1 in CML were sigificantly higher than that in non-leukemias and normal human . WT1 could be a marker for detecting minimal residual dis ease and evaluating therapeutic efficacy in CML.

About this research paper

What this paper is about

Objective:To establish a real time reverse transcription polymerase chain reaction method for detecting WT1 and to comprehend the expression levels of WT1 in chronic myeloid leukemia (CML) through examining peripheral blood of leuk emia patients.Method:39 CML patients, 26 non-leukemia patients and 16 normal human were included in this study. The method of real time RT-PCR detecting the expression of WT1 was established. The expresion levels of WT1 gene were tested using this method.Results:The expression levels of WT1 in 5 blastic crisis of CML patients were (312 000±126 965)copies/μg RNA, those of 19 within accelerat ed phase were (18 652±22 879)copies/μg, and those of 15 within chronic phase were (154±182)copies/μgRNA.Conclusion:Expression of WT1 in CML were sigificantly higher than that in non-leukemias and normal human . WT1 could be a marker for detecting minimal residual dis ease and evaluating therapeutic efficacy in CML.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To establish a real time reverse transcription polymerase chain reaction method for detecting WT1 and to comprehend the expression levels of WT1 in chronic myeloid leukemia (CML) through examining peripheral blood of leuk emia patients.Method:39 CML patients, 26 non-leukemia patients and 16 normal human were included in this study. The method of real time RT-PCR detecting the expression of WT1 was established. The expresion levels of WT1 gene were tested using this method.Results:The expression levels of WT1 in 5 blastic crisis of CML patients were (312 000±126 965)copies/μg RNA, those of 19 within accelerat ed phase were (18 652±22 879)copies/μg, and those of 15 within chronic phase were (154±182)copies/μgRNA.Conclusion:Expression of WT1 in CML were sigificantly higher than that in non-leukemias and normal human . WT1 could be a marker for detecting minimal residual dis ease and evaluating therapeutic efficacy in CML.

Key concepts: Medicine, Real-time polymerase chain reaction, Myeloid leukemia, Minimal residual disease, Leukemia, Reverse transcription polymerase chain reaction, Peripheral blood, breakpoint cluster region

Related papers

Back to paper searchBrowse research topicsOriginal source
The Detection of WT1 Gene Expression in Peripheral Blood of Acute Lymphocytic Leukemia Patients Using Real Time RT-PCR Method — Research Paper | ScholarLens